Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NSAP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
PHLDA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGXB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POM121C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMZ2P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DDX20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2C8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPDL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00896 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAOB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBGCP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFB2M - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on